Leveraging Pharmacogenomics Guidance for Personalized Care
February 22, 2017 — 08:30AM EST - 09:30AM EST
Orange County Convention Center
Pharmacogenomics can drive population health by optimizing drug therapy to ensure maximum efficacy with minimal adverse effects. The use of this technology by providers is expanding rapidly as the cost of testing decreases and the body of research-based, clinically actionable evidence grows. Hear about how timely pharmacogenetic guidance is being used today in clinical settings to provide targeted, data-driven, personalized therapies that improve outcomes and reduce costs. This session will also explore current initiatives in integrating pharmacogenomics test results and clinical decision support systems with mainstream electronic health record systems.
Summarize clinical case studies demonstrating how pharmacogenomics can be utilized
Recognize how pharmacogenomics directed prescribing reduces the incidence of adverse drug reactions and provides pharmacogenomic benefits to patients
Prepare for the impacts of genomic health insights on precision medicine and population health